Achieve Life Sciences

Achieve Life Sciences Inc. is a specialty pharmaceutical company focused on advancing cytisinicline as a widely accessible treatment option to help people combat nicotine addiction. It is a recognized smoking cessation therapy that has been approved and marketed in Central and Eastern Europe. Achieve's focus is addressing the global smoking health epidemic through the development and commercialization of cytisinicline. The company operates a division dedicated to the development and commercialization of cytisinicline for nicotine addiction.